重组人CD45/PTPRC(His标签)蛋白(94149ES)
产品应用
CD45, previously called LCA (leukocyte common antigen), T200, or Ly5 in mice, is member C of the class 1 (receptor-like) protein tyrosine phosphatase family (PTPRC). It is a variably glycosylated 180-220 kDa transmembrane protein that is abundantly expressed on all nucleated cells of hematopoietic origin. Galectin interaction can be fine-tuned by varying usage of the heavily O-glycosylated spliced regions and sialylation of N-linked carbohydrates. Within the IS, CD45 dephosphorylates and negatively regulates the Src family kinase, Lck . In other leukocytes, CD45 influences differentiation and links immunoreceptor signaling with cytokine secretion and cell survival, partially overlapping in function with DEP-1/CD148. CD45 deletion causes in severe immunodeficiency, while point mutations may be associated with autoimmune disorders .
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
333
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
331
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
425
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
312
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
2361
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
2229
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1348
2026-04-22
【应用方向】TNFR蛋白家族概述
1329
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1539
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
1112
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
1158
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1271
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
1025
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14864
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11474
2026-09-21





